← Back to Treatments
🏅 FDA Orphan Designation

Alphanate

Antihemophilic factor (human)

Manufacturer: Grifols Biologicals Inc.

Indicated for:
Pseudo-von Willebrand diseaseOrphanVon Willebrand disease

FDA-Approved Indications (2)

For surgical and/or invasive procedures in patients with von Willebrand Disease (VWD) in whom desmopressin is either ineffective or contraindicated. It is not indicated for patients with severe VWD (T…

For surgical and/or invasive procedures in patients with von Willebrand Disease (VWD) in whom desmopressin is either ineffective or contraindicated

Population: patients with VWD (excluding severe Type 3 VWD undergoing major surgery)

Indications & Usage

For surgical and/or invasive procedures in patients with von Willebrand Disease (VWD) in whom desmopressin is either ineffective or contraindicated. It is not indicated for patients with severe VWD (Type 3) undergoing major surgery

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.